FFA
MRNA icon

Farther Finance Advisors’s Moderna MRNA Stock Holding History

Farther Finance Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.39M Buy
17,622
+2,193
+14% +$236K 0.02% 560
2026
Q2 		$1.08M Sell
15,429
-4,782
-24% -$247K 0.01% 1049
2026
Q1 		$1.01M Buy
20,211
+15,569
+335% +$726K 0.01% 960
2025
Q4 		$137K Buy
4,642
+34
+0.7% +$924 ﹤0.01% 2147
2025
Q3 		$119K Sell
4,608
-175
-4% -$4.88K ﹤0.01% 1932
2025
Q2 		$132K Buy
4,783
+1,238
+35% +$32.6K ﹤0.01% 1608
2025
Q1 		$96.3K Buy
3,545
+26
+0.7% +$923 ﹤0.01% 1561
2024
Q4 		$146K Buy
3,519
+2,615
+289% +$125K 0.01% 1141
2024
Q3 		$60.4K Sell
904
-178
-16% -$16.3K ﹤0.01% 1544
2024
Q2 		$125K Buy
1,082
+271
+33% +$34.3K 0.01% 1036
2024
Q1 		$85.6K Buy
811
+203
+33% +$20.5K 0.01% 994
2023
Q4 		$60.4K Buy
608
+362
+147% +$30.4K ﹤0.01% 980
2023
Q3 		$25.4K Buy
246
+106
+76% +$11.8K ﹤0.01% 1015
2023
Q2 		$17K Buy
140
+26
+23% +$3.47K ﹤0.01% 1047
2023
Q1 		$17.5K Sell
114
-41
-26% -$6.76K 0.01% 942
2022
Q4 		$27.8K Buy
+155
New +$25.3K 0.01% 628

Other funds holding MRNA

GAA
Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
LHWM
Lake Hills Wealth Management Austin, Texas $218M AUM 31.66% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
G
Gainplan Bloomfield Hills, Michigan $258M AUM 17.9% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Farther Finance Advisors's MRNA Position: Q3 2026 in Review

Farther Finance Advisors increased its Moderna (MRNA) stake by 14% in Q3 2026, buying an estimated $236K and bringing the position to 17,622 shares worth $3.39M. The position accounts for 0.02% of the portfolio, ranked #560.

Farther Finance Advisors first reported a position in MRNA in Q4 2022 and has held it in 16 quarters since. 24 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Farther Finance Advisors held 17,622 shares of Moderna worth $3.39M as of Q3 2026.
  • Farther Finance Advisors bought 2,193 Moderna shares in Q3 2026, an estimated $236K.
  • Moderna made up 0.02% of Farther Finance Advisors's portfolio in Q3 2026, its #560 holding.
  • Farther Finance Advisors first reported a position in Moderna in Q4 2022 and has held it in 16 quarters since.
  • 24 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.